New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2012
08:05 EDTCYTX
theflyonthewall.com: Cytori receives approval from FDA to initiate U.S. cardiac cell therapy trial
Cytori Therapeutics has received an Investigational Device Exemption, IDE, approval from the U.S. FDA to begin the ATHENA trial. ATHENA will investigate the use of the Celution® System, an innovative medical device to prepare adipose-derived stem and regenerative cells, ADRCs, to treat a form of coronary heart disease, chronic myocardial ischemia, CMI. The IDE application was originally submitted to the FDA in December 2011. :theflyonthewall.com



News For CYTX From The Last 14 Days
Check below for free stories on CYTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for these search parameters.